Clinical effects of granisetron and methylpredonisolone against delayed emesis and anorexia induced by anticancer agents
Kawashima, T.; Wada, T.; Morita, N.; Okamoto, K.; Matsuhira, J.; Sakamoto, T.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(16): 2849-2851
1994
ISSN/ISBN: 0385-0684 PMID: 7993127 Document Number: 429517
Document emailed within 1 workday
Related Documents
Feng, F.; Zhang, P.; He, Y.; Li, Y.; Zhou, M.; Chen, G.; Li, L. 2002: Clinical comparison of the selective serotonin3 antagonists ramosetron and granisetron in treating acute chemotherapy-induced emesis, nausea and anorexia Chinese Medical Sciences Journal 17(3): 168-172Endo, T.; Hamaue, N.; Ihira, E.; Teramoto, Y.; Liu, Y.; Hirafuji, M.; Minami, M. 2002: Effects of granisetron, a 5-HT3 receptor antagonist, on 5-hydroxytryptamine (5-HT) release from the isolated ileum in a delayed-emesis rat model Research Communications in Molecular Pathology and Pharmacology 111(1-4): 55-68
Nukariya, N.; Nakarai, I.; Kobayashi, H.; Koizumi, W.; Komatsu, H.; Uchiyama, T.; Yamaguchi, T.; Taira, O.; Minato, K.; Futatsugi, K. 1995: A comparative study of the effect of granisetron and a combination of granisetron plus steroids on cancer chemotherapy induced emesis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(12): 1821-1829
Endo, T.; Sugawara, J.; Nemoto, M.; Minami, M.; Blower, P.R. 1998: Effects of granisetron, a selective 5-HT3 receptor antagonist, on ouabain-induced emesis in ferrets Research Communications in Molecular Pathology and Pharmacology 102(3): 227-239
Perez, E.A.; Gandara, D.R. 1994: The clinical role of granisetron (Kytril) in the prevention of chemotherapy-induced emesis Seminars in Oncology 21(3 Suppl. 5): 15-21
Marty, M. 1990: A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S28-S32
Heron, J.F. 1995: Single-agent oral granisetron for the prevention of acute cisplatin-induced emesis: a double-blind, randomized comparison with granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone Seminars in Oncology 22(4 Suppl. 10): 24-30
Kitada, M.; Sawaragi, I. 1996: Clinical evaluation of granisetron hydrochloride against nausea and vomiting induced by anticancer drugs for gynecological malignant tumors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(1): 87-91
Prentice, H.G.; Cunningham, S.; Gandhi, L.; Cunningham, J.; Collis, C.; Hamon, M.D. 1995: Granisetron in the prevention of irradiation-induced emesis Bone Marrow Transplantation 15(3): 445-448
Chiou, T.J.; Wei, C.H.; Hsieh, R.K.; Fan, F.S.; Liu, J.H.; Chen, P.M. 1995: Comparison of intravenous granisetron with metoclopramide in the treatment of chemotherapy-induced emesis Zhonghua Yi Xue Za Zhi 56(1): 23-30
Hesketh, P. 1995: Prophylaxis with oral granisetron for acute emesis induced by moderately emetogenic chemotherapy Seminars in Oncology 22(4 Suppl 10): 19-23
Hunter, A.E.; Prentice, H.G.; Pothecary, K.; Coumar, A.; Collis, C.; Upward, J.; Murdoch, R.; Gandhi, L.; Hamon, M.; Butler, M. 1991: Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation Bone Marrow Transplantation 7(6): 439-441
Cupissol, D.R.; Serrou, B.; Caubel, M. 1990: The efficacy of granisetron as a prophylactic anti-emetic and intervention agent in high-dose cisplatin-induced emesis European Journal of Cancer 26(Suppl 1): S23-S27
Yamada, T.; Tanaka, N.; Yokoi, K.; Ishikawa, N.; Seya, T.; Horiba, K.; Kanazawa, Y.; Shirakawa, T.; Ohkawa, K.; Kudoh, H.; Koizumi, M.; Yoshioka, M.; Tajiri, T. 2007: Substance P and anticancer drug-induced emesis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(6): 903-906
Li, Y.T.; Mau, Y.K.; Hsu, K.P. 1991: Control of cisplatin-induced delayed emesis Zhonghua Yi Xue Za Zhi 48(6): 451-455
Miyazaki, Y.; Miyazaki, S.; Fujita, S.; Hirose, H.; Sugimoto, S.; Michiura, T.; Yamabe, K.; Nagaoka, M. 2014: A case of advanced rectal cancer with irinotecan (CPT-11)-induced delayed emesis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(12): 1835-1837
Hagiwara, A.; Takahashi, T. 1987: A new drug-delivery-system of anticancer agents: activated carbon particles adsorbing anticancer agents In Vivo 1(4): 241-252
Tabona, M.V. 1990: An overview on the use of granisetron in the treatment of emesis associated with cytostatic chemotherapy European Journal of Cancer 26(Suppl 1): S37-S44
Garcia-del-Muro, X.; Vadell, C.; Pérez Manga, G.; Bover, I.; Rifá, J.; Beltrán, M.; Barros, M.M.; Germá, J.R.; Fabregat, X.; Moreno, V.; Salvador, A.; Viladiu, P. 1998: Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis European Journal of Cancer 34(1): 193-195
Hellenbrecht, D.; Saller, R. 1986: Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis Arzneimittel-Forschung 36(12): 1845-1849